Alice Panchaud pharmacienne suisse
Panchaud, Alice
VIAF ID: 315731936 (Personal)
Permalink: http://viaf.org/viaf/315731936
Preferred Forms
- 100 0 _ ‡a Alice Panchaud ‡c pharmacienne suisse
- 100 1 _ ‡a Panchaud, Alice
-
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study | |
Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft | |
Association between confirmed congenital Zika infection at birth and outcomes up to 3 years of life | |
Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain | |
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications. | |
Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. | |
Clinical management of pregnant women exposed to Zika virus | |
A critical analysis of the neurodevelopmental and neurosensory outcomes after 2 years for children with in utero Zika virus exposure | |
[Drugs and breastfeeding: some facts to consider before deciding they are incompatible] | |
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes | |
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy | |
Harness shared data in international Zika registry | |
Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance | |
L’impact de l’infection par le virus Zika pendant la grossesse à la suite des épidémies dans les Caraïbes et en Asie du Sud-Est. | |
Impact of Zika virus infection during pregnancy following epidemic events in the Caribbean and in South East Asia | |
Infant Exposure to Methylphenidate and Duloxetine During Lactation | |
An international registry for emergent pathogens and pregnancy | |
Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis | |
Management of Deficient Lactation in Switzerland and Canada: A Survey of Midwives' Current Practices | |
Médicaments et allaitement : quelques éléments à considérer avant de les juger incompatibles | |
Médicaments, grossesse et lactation | |
Monkeypox and pregnancy: forecasting the risks | |
Outbreak in meldonium positive laboratory tests: are we missing something? | |
Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study | |
Place des apports oraux en acides gras oméga-3 dans la mucoviscidose | |
Placental infection by Zika virus in French Guiana | |
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals | |
Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure. | |
Pregabalin use early in pregnancy and the risk of major congenital malformations | |
Pregnancy outcome following maternal exposure to pregabalin may call for concern | |
Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. | |
Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services. | |
Preliminary results of venlafaxine exposure in pregnancy, a multicenter prospective cohort ENTIS study | |
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report. | |
Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey | |
Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients | |
Safety of metformin exposure during the first trimester of pregnancy : an observational cohort study in the French nationwide healthcare data system. | |
Sars-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care | |
Sécurité d’utilisation de la metformine au cours de la grossesse : étude pharmaco-épidémiologique à partir du système national des données de santé | |
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale. | |
[SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio] | |
Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometry. | |
Tachysystole and risk of cesarean section after labor induction using misoprostol: A cohort study | |
Use of atypical antipsychotics in pregnancy and maternal gestational diabetes | |
Utility of an Algorithm to Increase the Accuracy of Medication History in an Obstetrical Setting | |
Vertical transmission and materno-fetal outcomes in 13 patients with COVID-19 | |
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry | |
Zika virus: are we going too far? | |
Zika virus during pregnancy: From maternal exposure to congenital Zika virus syndrome | |
Zika virus, vaccines and antiviral strategies. |